A comparison of statistical methods to predict the residual lifetime risk
Abstract Lifetime risk measures the cumulative risk for developing a disease over one’s lifespan. Modeling the lifetime risk must account for left truncation, the competing risk of death, and inference at a fixed age. In addition, statistical methods to predict the lifetime risk should account for covariate-outcome associations that change with age. In this paper, we review and compare statistical methods to predict the lifetime risk. We first consider a generalized linear model for the lifetime risk using pseudo-observations of the Aalen-Johansen estimator at a fixed age, allowing for left truncation. We also consider modeling the subdistribution hazard with Fine-Gray and Royston-Parmar flexible parametric models in left truncated data with time-covariate interactions, and using these models to predict lifetime risk. In simulation studies, we found the pseudo-observation approach had the least bias, particularly in settings with crossing or converging cumulative incidence curves. We illustrate our method by modeling the lifetime risk of atrial fibrillation in the Framingham Heart Study. We provide technical guidance to replicate all analyses in R..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
European journal of epidemiology - 37(2022), 2 vom: 03. Jan., Seite 173-194 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Conner, Sarah C. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Competing risks |
---|
Anmerkungen: |
© Springer Nature B.V. 2021 |
---|
doi: |
10.1007/s10654-021-00815-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR046606726 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR046606726 | ||
003 | DE-627 | ||
005 | 20230519182132.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220329s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10654-021-00815-8 |2 doi | |
035 | |a (DE-627)SPR046606726 | ||
035 | |a (SPR)s10654-021-00815-8-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Conner, Sarah C. |e verfasserin |0 (orcid)0000-0002-0929-9948 |4 aut | |
245 | 1 | 2 | |a A comparison of statistical methods to predict the residual lifetime risk |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Springer Nature B.V. 2021 | ||
520 | |a Abstract Lifetime risk measures the cumulative risk for developing a disease over one’s lifespan. Modeling the lifetime risk must account for left truncation, the competing risk of death, and inference at a fixed age. In addition, statistical methods to predict the lifetime risk should account for covariate-outcome associations that change with age. In this paper, we review and compare statistical methods to predict the lifetime risk. We first consider a generalized linear model for the lifetime risk using pseudo-observations of the Aalen-Johansen estimator at a fixed age, allowing for left truncation. We also consider modeling the subdistribution hazard with Fine-Gray and Royston-Parmar flexible parametric models in left truncated data with time-covariate interactions, and using these models to predict lifetime risk. In simulation studies, we found the pseudo-observation approach had the least bias, particularly in settings with crossing or converging cumulative incidence curves. We illustrate our method by modeling the lifetime risk of atrial fibrillation in the Framingham Heart Study. We provide technical guidance to replicate all analyses in R. | ||
650 | 4 | |a Competing risks |7 (dpeaa)DE-He213 | |
650 | 4 | |a Cumulative incidence |7 (dpeaa)DE-He213 | |
650 | 4 | |a Lifetime risk |7 (dpeaa)DE-He213 | |
650 | 4 | |a Left truncation |7 (dpeaa)DE-He213 | |
650 | 4 | |a Survival analysis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Time-to-event data |7 (dpeaa)DE-He213 | |
700 | 1 | |a Beiser, Alexa |4 aut | |
700 | 1 | |a Benjamin, Emelia J. |4 aut | |
700 | 1 | |a LaValley, Michael P. |4 aut | |
700 | 1 | |a Larson, Martin G. |4 aut | |
700 | 1 | |a Trinquart, Ludovic |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of epidemiology |d [Cham] : Springer Nature Switzerland AG, 1985 |g 37(2022), 2 vom: 03. Jan., Seite 173-194 |w (DE-627)SPR01240280X |w (DE-600)2004992-4 |x 1573-7284 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2022 |g number:2 |g day:03 |g month:01 |g pages:173-194 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10654-021-00815-8 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 37 |j 2022 |e 2 |b 03 |c 01 |h 173-194 |